au.\*:("ZIMMERMANN, Johann")
Results 1 to 7 of 7
Selection :
Modeling of the binding mode of a non-covalent inhibitor of the 20S proteasome. Application to structure-based analogue designFURET, Pascal; IMBACH, Patricia; FÜRST, Peter et al.Bioorganic & medicinal chemistry letters (Print). 2001, Vol 11, Num 10, pp 1321-1324, issn 0960-894XArticle
The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cellsMAISO, Patricia; OCIO, Enrique M; GARAYOA, Mercedes et al.British journal of haematology. 2008, Vol 141, Num 4, pp 470-482, issn 0007-1048, 13 p.Article
Entry into a new class of potent Proteasome inhibitors having high antiproliferative activity by structure-based designFURET, Pascal; IMBACH, Patricia; GARCIA-ECHEVERRIA, Carlos et al.Journal of medicinal chemistry (Print). 2004, Vol 47, Num 20, pp 4810-4813, issn 0022-2623, 4 p.Article
Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesisMOSER, Christian; SCHACHTSCHNEIDER, Philipp; LANG, Sven A et al.European journal of cancer (1990). 2008, Vol 44, Num 11, pp 1577-1586, issn 0959-8049, 10 p.Article
The isopeptidase USP2a protects human prostate cancer from apoptosisPRIOLO, Carmen; DAN TANG; FEBBO, Phillip et al.Cancer research (Baltimore). 2006, Vol 66, Num 17, pp 8625-8632, issn 0008-5472, 8 p.Article
A cathepsin K inhibitor reduces breast cancer-induced osteolysis and skeletal tumor burdenLE GALL, Céline; BELLAHCENE, Akeila; BONNELYE, Edith et al.Cancer research (Baltimore). 2007, Vol 67, Num 20, pp 9894-9902, issn 0008-5472, 9 p.Article
Structure-based optimisation of 2-aminobenzylstatine derivatives: Potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasomeFURET, Pascal; IMBACH, Patricia; FUERST, Peter et al.Bioorganic & medicinal chemistry letters (Print). 2002, Vol 12, Num 10, pp 1331-1334, issn 0960-894XArticle